» Articles » PMID: 17907173

CXCR5- and CCR7-dependent Lymphoid Neogenesis in a Murine Model of Chronic Antigen-induced Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2007 Oct 2
PMID 17907173
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease with unknown etiology and only partially defined pathogenesis. The aim of this study was to establish a murine model of chronic arthritis in which the development of tertiary lymphoid tissue, a hallmark of human RA, is locally induced, and to characterize the roles of the homeostatic chemokine receptors CXCR5 and CCR7 in this process.

Methods: We developed a modified model of chronic antigen-induced arthritis (AIA) in mice with a strong bias toward inflammation. Disease pathology was assessed up to 9 months in wild-type, CXCR5-deficient, and CCR7-deficient mice by determination of knee joint swelling and cellular and humoral immune responses, as well as by histologic analysis of arthritic knee joints.

Results: In this novel model of AIA, mice developed organized ectopic lymphoid follicles with topologically segregated B cell and T cell areas, high endothelial venules, and germinal center formation within the chronically inflamed synovial tissue. Analysis of the initiation and progression of AIA in wild-type, CXCR5-/-, and CCR7-/- mice revealed a reduction of acute inflammatory parameters in both knockout strains as well as significantly reduced joint destruction in CXCR5-/- mice. Most importantly, the development and organization of tertiary lymphoid tissue were significantly impaired in CXCR5-deficient and CCR7-deficient mice.

Conclusion: Our results suggest that an inflammatory microenvironment efficiently triggers lymphoid neogenesis in autoimmune diseases such as RA. Moreover, the generation of autoreactive tertiary lymphoid tissues, which is entirely dependent on homeostatic chemokines, may in turn maintain local aberrant chronic immune responses.

Citing Articles

Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances.

Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z Signal Transduct Target Ther. 2024; 9(1):225.

PMID: 39198425 PMC: 11358547. DOI: 10.1038/s41392-024-01947-5.


Tertiary lymphoid structures in anticancer immunity.

Teillaud J, Houel A, Panouillot M, Riffard C, Dieu-Nosjean M Nat Rev Cancer. 2024; 24(9):629-646.

PMID: 39117919 DOI: 10.1038/s41568-024-00728-0.


Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.

Rosenberg M, Greenstein E, Buchkovich M, Peres A, Santoni-Rugiu E, Yang L Cell Rep. 2023; 42(8):112879.

PMID: 37537844 PMC: 10551040. DOI: 10.1016/j.celrep.2023.112879.


Immune surveillance and humoral immune responses in kidney transplantation - A look back at T follicular helper cells.

Subburayalu J Front Immunol. 2023; 14:1114842.

PMID: 37503334 PMC: 10368994. DOI: 10.3389/fimmu.2023.1114842.


Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis.

Magliozzi R, Howell O, Calabrese M, Reynolds R Nat Rev Neurol. 2023; 19(8):461-476.

PMID: 37400550 DOI: 10.1038/s41582-023-00838-7.